home / stock / abbv / abbv articles

ABBV Articles, AbbVie Inc. - From 03/21/24

Stock Information
Company Name: AbbVie Inc.
Stock Symbol: ABBV
Market: NYSE
Website: abbvieinvestor.com
Menu
ABBV ABBV Quote ABBV Short ABBV News ABBV Articles ABBV Message Board
Get ABBV Alerts

News, Short Squeeze, Breakout and More Instantly...
AbbVie Recent Insider Activity | Benzinga

Making a noteworthy insider sell on March 20, Jeffrey R. Stewart, EVP at AbbVie (NYSE:ABBV), is reported in the latest SEC filing. What Happened: A...
Parvus Announces Collaboration with AbbVie to Develop IBD Therapies Based on the Parvus Navacim Platform Technology | Benzinga

South San Francisco, CA March 20, 2024 --(PR.com)-- The collaboration will combine AbbVie’s expertise in Immunology with Parvus’ innova...

Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today | Benzinga

AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 2.52% on an annualized basis producing an average annual return of 13.21%....

Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today? | Benzinga

On Sunday, MoonLake Immunotherapeutics (NASDAQ:MLTX) announced that continued treatment with Nanobody sonelokimab led to significant impr...
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields | Benzinga

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...

Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years | Benzinga

AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 2.73% on an annualized basis producing an average annual return of 13.17%....

Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today? | Benzinga

Friday, Alvotech (NASDAQ:ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE:TEVA...
Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freeport-McMoRan Inc. (NYSE: FCX) could go higher by a "couple of poi...

UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst | Benzinga

UBS initiated coverage on Axsome Therapeutics Inc (NASDAQ:AXSM), a biotech firm focused on developing and marketing therapies for ce...

AbbVie Analysts Boost Their Forecasts Following Strong Earnings | Benzinga

AbbVie Inc (NYSE: ABBV) reported better-than-expected fourth-quarter earnings on Friday. AbbVie reported fourth-quarter adjusted EPS of $2.79, dow...
Previous 10 Next 10